Delivery Order SPE2DB22D2211-SPE2DB25FSCMX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,117.03 to AmerisourceBergen Drug Corp for the supply of Cetirizine-Pseudoephedrine ER 5-120 mg tablets (24-count packages) on May 12, 2025, with a completion date of May 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The pharmaceutical products will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,979.76 to AmerisourceBergen Drug Corp for the supply of Cetirizine-Pseudoephedrine Extended Release 5-120 mg tablets (24-count packages). This non-set-aside, firm fixed price delivery order was awarded on August 27, 2025, with an ultimate completion date of August 28, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,698.47 to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Cetirizine-Pseudoephedrine ER 5-120 mg tablets in quantities of 12 units. The contract, designated as non-set-aside and utilizing firm fixed-price terms, is scheduled for completion by December 11, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a $1,268.45 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Cetirizine HCL 5 mg tablets (100 count). The contract is a firm fixed price delivery order with an ultimate completion date of December 8, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on August 14, 2025, for Cetirizine HCL 10 mg tablets (100-count) with a ceiling value of $1,088.45. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 15, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's extensive role as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Cetirizine HCL 5 mg tablets (100-count units) with a ceiling value of $12,853.67. This firm fixed-price delivery order, set to conclude by September 15, 2025, represents a routine pharmaceutical procurement to support federal medical supply requirements. The contract is non-set-aside and was competitively awarded, reflecting AmerisourceBergen's established capability as a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Cetirizine HCL 10 mg tablets (300 count) with a ceiling value of $1,500.09. The contract employs firm fixed-price terms with an ultimate completion date of November 5, 2025, and represents a non-competitive set-aside delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order valued at $1,770.43 to AmerisourceBergen Drug Corp for the supply of Cetirizine HCL 5 mg tablets (100-count units) on July 14, 2025, with completion scheduled for July 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cetirizine HCL 5 mg tablets (100-count) with a contract value of $4,896.02 and an ultimate completion date of October 31, 2025. This is a firm fixed-price delivery order issued without set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,877.84 to AmerisourceBergen Drug Corp for Cetirizine HCL 5 mg tablets (100-count units) on September 25, 2025, with an ultimate completion date of September 26, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The contract is structured as a child order under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSCMXDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Cetirizine-Pseudoephedrine Extended Release 5-120 mg tablets in quantities of 24 units. This firm fixed price delivery order, valued at $1,355.54, represents a non-competitive set-aside and supports federal pharmaceutical procurement needs. The contract is scheduled for completion by August 11, 2025, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.999 billion master agreement running through December 2026 that provides comprehensive global pharmaceutical support to military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant role in federal medical supply chains serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contracting portfolio demonstrates extensive capability in delivering a wide range of pharmaceutical products, including specialty medications, vaccines, and medical supplies across multiple therapeutic domains. This particular delivery order for antihistamine-decongestant combination therapy reflects the routine pharmaceutical supply requirements that support military and veteran healthcare operations, consistent with the company's established role as a critical vendor in the federal medical procurement ecosystem.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/8/25 |